Glycominds Ltd.

Mission :

Glycominds' mission  is to become the market leader for autoimmune diseases' specialty tests.

Glycominds Ltd. is a Specialty Tests Company focused on the commercialization of proprietary biomarkers for autoimmune diseases, the largest unmeet need tests market.
 

• Our High value IP-based MS prognostic test is in its validation phase via the multi-center DECISION study – steered by a committee of top North American MS thought leaders. The MS predictor will be launched as analyte specific reagent (ASR) in the US market within 12 months.
  
   
• Our pipeline includes tests for other autoimmune diseases - among the most recognized and poorly understood of illnesses, where we found the largest unmet need for specialty tests. We offer a powerful comprehensive solution to this overlooked market. Using glycan molecules as probes via our proprietary GlycoChip® technology, our continuous pipeline of proprietary biomarkers includes:
  • IBD differential diagnosis product (Chron’s Disease vs. Ulcerative Colitis) is about 9 months from the market. Additional opportunities for Irritable bowel syndrome (IBS) based on the same biomarker are under feasibility process.
  • Rheumatoid Arthritis (RA) prognosis and Osteoarthritis (OA) disease management are additional projects that are currently in the discovery phase.

    Careers at Glycominds Click here

    Submit your resume online to Glycominds Jobs

    Glycominds Ltd.
    1 Yodfat St.,
    Alon Building, Global Park
    Lod 71291, Israel
    
    Phone: +972-8-9181080
    Toll free: 1-866-2906940
       (from US and Canada)
    Fax: +972-8-9181081